Nathaniel M Hawkins
Prof Nathaniel M Hawkins, MD, MBChB, MPH, FESC is an expert in Cardiology at Vancouver General Hospital (Canada). As of October 2026, ScienceLeadR ranks Nathaniel M Hawkins in the top 1% of experts worldwide for Heart Failure. Nathaniel M Hawkins has authored 219 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 2 of them ongoing. SLR score: 842 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Pulmonology - Public Health - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 219
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Historical Drug Costs Among Elderly Patients Hospitalized with Heart Failure in Canada, 2013-2014 to 2018-2019. PMID 42756717 — heart failure, pharmaceutical preparations, heart, retrospective studies, aged, drug costs | CJC Open | 2026 | 0 |
| Non-Physician-Led Models of Care for Heart Failure Medication Optimization: A Scoping Review. PMID 42483007 — heart failure, heart, nursing, pharmacy, physicians, therapeutics | CJC Open | 2026 | 2 |
| Cost-effectiveness of Pharmacist- and Nurse Practitioner-led Medication Management for Heart Failure With Reduced Ejection Fraction. PMID 42370863 — nurses, nurse practitioners, hospitalization, heart failure, heart, nursing, pharmacists, pharmacy, cardiology, heart failure, systolic, quality-adjusted life years | Can J Cardiol | 2026 | 0 |
| Heart failure and COPD - guideline adherence, diagnostic characterisation and treatment quality. PMID 42185148 — guideline adherence, heart failure, internal medicine, heart, pulmonary disease, chronic obstructive, therapeutics | Eur J Intern Med | 2026 | 0 |
| Impact of routine urine sodium evaluation on diuretic practices in patients with acute heart failure. PMID 42043186 — research design, diuresis, heart failure, heart, natriuresis, diuretics, furosemide | ESC Heart Fail | 2026 | 0 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY SYMPHONY HF NCT05919342 — registries, heart failure, heart, cardiovascular diseases, biomarkers, echocardiography, diagnosis, natriuretic peptides, therapeutics | N/A | Recruiting | 2022 |
| Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure NCT05859048 — research design, early diagnosis, intelligence, laboratories, blood, heart failure, heart, blood pressure, physical examination, electronic health records, natriuretic peptide, brain, echocardiography, diagnosis, natriuretic peptides, records, artificial intelligence | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map